Compare · GHM vs TMO
GHM vs TMO
Side-by-side comparison of Graham Corporation (GHM) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GHM and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $257.53B, about 308.4x GHM ($835.1M).
- TMO has been more active in the news (7 items in the past 4 weeks vs 3 for GHM).
- TMO has more recent analyst coverage (25 ratings vs 10 for GHM).
- Company
- Graham Corporation
- Thermo Fisher Scientific Inc
- Price
- $68.44-3.60%
- $690.13-0.92%
- Market cap
- $835.1M
- $257.53B
- 1M return
- -
- +4.77%
- 1Y return
- -
- +28.01%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 1978
- News (4w)
- 3
- 7
- Recent ratings
- 10
- 25
Graham Corporation
Graham Corporation, together with its subsidiaries, designs, manufactures, and supplies vacuum and heat transfer equipment for the chemical, defense, petrochemical, petroleum refining, power generation/alternative energy, and other industries. It offers heat transfer equipment, including surface condensers, heliflows, water heaters, and various types of heat exchangers, as well as custom-engineered ejectors; vacuum equipment, such as steam jet ejector vacuum systems and liquid ring vacuum pumps; and turbomachinery products for the aerospace, cryogenic, defense, and energy markets. The company also services and sells spare parts for its equipment. It sells its products directly, as well as through independent sales representatives in the United States, the Middle East, Canada, Asia, South America, and internationally. Graham Corporation was founded in 1936 and is headquartered in Batavia, New York.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest GHM
- Analyst initiated coverage on Graham with a new price target
- Director Gregorio Mauro gifted 936 shares, closing all direct ownership in the company (SEC Form 4)
- Amendment: Director Gregorio Mauro bought $58,812 worth of shares (1,200 units at $49.01) (SEC Form 4)
- SEC Form 4 filed by Graham Corporation
- SEC Form 8-K filed by Graham Corporation
- SEC Form 4 filed by Chief Growth & Enblmnt Officer Scholes Richard Alan
- SEC Form 3 filed by new insider Scholes Richard Alan
- Graham Corporation Announces Leadership Addition to Support Growth Phase
- SEC Form 10-Q filed by Graham Corporation
- SEC Form 8-K filed by Graham Corporation
Latest TMO
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- SEC Form 4 filed by Director Keith R. Alexandra
- Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
- Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)